Mechanical Aspiration in ST Elevation ACS

In ST elevation ACS the preferred treatment is primary PCI. However, one its limitations is thrombus presence and its distal embolization, which threatens microcirculation perfusion and is therefore associated to ventricular function deterioration and bad evolution.

Aspiración mecánica en el IAM con supradesnivel del ST

Manual thrombus aspiration has been tested in different studies but the problem remains unsolved; mechanical thrombectomy might be a solution to this complication, so difficult to handle. 

The CHEETAH study (prospective, multicenter) included 400 patients with ST-ACS presenting within 12 hrs. of symptom onset treated with mechanical thrombectomy with CAT RX Aspiration System (Penumbra Inc, Alameda CA). 

Primary end point was a composite of cardiovascular death, repeat MI, cardiogenic shock or new class IV cardiac failure at 30 days.

Mean age was 60, most patients were men, 25% were diabetic, 2% had prior CABG and 20% prior PCI.

Most patients were in Killip class I-II. Compromised arteries were the right coronary, in half of patients, followed by the anterior descending and, less frequently, the circumflex. 

Read also: ACC 2023 | Subanalysis of the REVIVED-BICS Study2.

 Final rates of TIMI 0 was 99.50%, TIMI flow 3, 97.50% and myocardial blush grade 3 was 99.75%, with no device complications. 

Primary end point occurred in 3.6% of cases (95% CI, 2.0–6.0%) compared against the historical rate of 6.1%  (Pnoninferiority <0.001).

At 30 days, cardiovascular mortality was 0.51%, stroke 0.77%, major bleeding 1%.

Conclusion

Mechanical aspiration before PCI in acute coronary syndrome with high thrombus burden was safe, and was associated to high thrombus removal with flow restauration and normal perfusion on final angiography. 

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board ofSOLACI.org.

Original Title: Sustained Mechanical Aspiration Thrombectomy for High Thrombus Burden Coronary Vessel Occlusion: The Multicenter CHEETAH Study.

Reference: S. Jay Mathews, et al. Circ Cardiovasc Interv. 2023;16:e012433. DOI: 10.1161/CIRCINTERVENTIONS.122.012433. 


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

CRABBIS Trial: Comparison of Different Provisional Stenting Sequences

Provisional stenting (PS) is the gold standard for percutaneous coronary intervention (PCI) in most patients with coronary bifurcation lesions (CBL). Moreover, recent studies such...

Andromeda Trial: Meta-Analysis of Drug Coated Balloon vs. DES in Small Vessel DeNovo Lesions

The use of coronary stents vs plain old balloon angioplasty (POBA), has allowed to reduce recoil and limiting flow dissection which were major limitation...

QFR vs. FFR: Is Coronary Revascularization Deferral Safe? Results from a FAVOR III Sub-Analysis

In cases of intermediate coronary lesions, functional assessment is recommended to aid the decision-making process regarding revascularization. There are several tools currently used to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

STRIDE: Semaglutide in Patients with Peripheral Arterial Disease and Type II Diabetes

Peripheral arterial disease (PAD) is a severe complication in patients with type II diabetes, primarily affecting peripheral vessels, especially below-the-knee (BTK) arteries. This condition...